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1. Introduction 
The molecular nature of the Rho(D) antigen of 
the human erythrocyte blood group has remained 
most controversial. Although several studies agree 
that the antigen is an integral membrane protein, Mr 
estimates vary from 7000-l 80 000 [l-4]. We have 
now radioactively surface-labeled Rho(D) positive 
and negative erythrocytes using the r2’I/lactoperoxi- 
dase method. The labeled membrane proteins were 
solubilized in Triton X-lOOcontaining buffer and 
immunoprecipitated with anti-Rho(D) antisera. The 
precipitates were analysed by sodium dodecyl sulfate 
(SDS)-polyacrylamide slab gel electrophoresis. The 
results show that only from Rho(D) positive mm- 
branes a single minor polypeptide with app. Mr 
28 000-33 000 could be precipitated specifically. 
Its behavior during electrophoresis indicated a hydro- 
phobic nature. It may lack carbohydrate because it 
was not labeled using carbohydrate-specific surface 
labeling techniques. 
10 min, the supernatants were recovered and sub- 
jected to immunoprecipitations. These were performed 
using protein A-containing Staphylococcus aureus 
cells as detailed in [7]. SDS-polyacrylamide slab gel 
electrophoresis was done as in [8]. After electropho- 
resis the gels were fixed, treated for fluorography [9] 
and exposed to Kodak RP X-Omat film. “C-Labeled 
standard proteins were obtained from the Radiochem- 
ical Centre, Amersham. The app. Mr of the Rho(D) 
antigen was determined as in [lo]. Red cells were 
labeled by the periodate/NaB3H4 and neuraminidase- 
galactose oxidase/NaB3H4 methods as in [6,11]. 
3. Results 
2. Materials and methods 
Human red cells were Rho(D) typed by standard 
techniques. The red cells and the anti-Rho(D) specific 
antisera were obtained from the Finnish Red Cross 
Blood Transfusion Centre, Helsinki. The red cells 
were radioactively labeled by lactoperoxidasecatalyzed 
iodination in the presence of D-glucose and glucose 
oxidase [.5]. The membranes were isolated [6] and 
solubilized in 0.15 M NaCl-0.01 M sodium phosphate 
(pH 7.4)-l% Triton X-100-1% ethanol-2 mM phen- 
ylmethylsulfonyl fluoride at O’C. All subsequent 
operations until denaturation with SDS were done at 
0-4’C. After centrifugation at 5000 rev./min for 
Fig.1 shows a polyacrylamide slab gel of erythro- 
cyte surface proteins and immunoprecipitates obtained 
with anti-Rho(D) antiserum. A surface-labeled protein 
(marked with the heavy arrow) was specifically pre- 
cipitated from the Rho(D) positive membranes 
(fig.lD,F,H) with antiserum. Non-immune sera did 
not precipitate the polypeptide (fig.lE,G,I), neither 
did antiserum from Rho(D) negative membranes 
(fig.1 J,L). The app. M, of the Rho(D) antigen on 
12% acrylamide gel was 33 000. When immunoprecip- 
itates were analyzed using 8% acrylamide gels, the 
app.Mr was 28 000 (fig2D). An identical polypeptide 
was obtained from En(a-) Rho(D) positive membranes 
(flg.2F), which lack glycophorin A and contain an 
overglycosylated band 3 [ 12-141. 
The Rho(D) antigen is evidently a minor component 
of the membrane. When 1251-labeled membranes were 
directly analyzed by polyacrylamide slab-gel electro- 
phoresis followed by fluorography no labeled poly- 
peptide was seen in the position of the Rho(D) antigen 
after a relatively short exposure to X-ray film (fig3B). 
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Fig.1. Fluorography pattern of a 12% polyacrylamide slab gel of immunoprecipitated Rho(D) antigens from 1Z51-labeled red cell 
membranes: (A) 14C-labeled standard proteins [M, myosin; PHb, phosphorylase b; BSA, bovine serum albumin; OA, ovalbumin; 
CA, carbonic anhydrase; L, lysozyme]; (B) pattern of periodate/NaBSH4-labeled red cell membranes [CPA-D, glycophorin A 
dimer; CPA-M, glycophorin A monomer; GPB, glycophorin B]; (C) pattern of lZSI-labeled red cell membranes; (D,F,H) patterns 
obtained by immunoprecipitation with anti-Rho(D) antiserum from Rho(D) positive red cell membranes; B3, band 3 (nomen- 
clature from [ 231). Heavy arrow points to the position of the Rho(D) antigen; (E,G,I) patterns obtained with non-immune sera 
from identical samples as in (D,F,H); (J,L) patterns obtained with antiserum from Rho(D) negative red cell membranes; (K,M) 
patterns obtained with non-immune serum from identical samples as in (J,L). 
Fig.2. 
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Fig.3. Fluorography pattern of a 12% slab gel of surface-labeled red cells and Rho(D) antigen treated with pronase: (A) pattern of 
periodate/NaB3H,-labeled red cell membranes: (B) pattern of “‘I-labeled Rho(D) positive red cell membranes; (C) as in (B) but 
exposed to X-ray fii for a longer time; (D) patterns obtained with anti-Rho(D) antiserum from Rho(D) positive “*I-labeled 
membranes; (E) an identical immunoprecipitate as in (D) which was treated subsequently with 1% pronase in 1% SDS for 1 h at 
37°C; (F) pattern obtained with nonimmune serum from an identical sample as in (D). Symbols as in legend to fig.1; ( _ ) 
Rho(D) antigen. 
A longer exposure visualized alabeled component in 
that position (fig3C, arrow). The protein nature of 
the antigen was ascertained by protease digestion. 
Fig3D shows the immunoprecipitated antigen, and 
it was completely degraded by pronase (fig3E). Only 
some low M, peptides remained in the region of the 
buffer front (BF). 
4. Discussion 
Here I have shown that a surfaceexposed polypep- 
tide with an app. h4,28 000-33 000 was specifically 
immunoprecipitated from Rho(D) positive red cell 
membranes using anti-Rho(D) antiserum. The poly- 
peptide has now been immunoprecipitated from 
Fig.2. Fluorography pattern of an 8% polyacrylamide slab gel of Rho(D) antigens immunoprecipitated from normal ‘Z51-labeled 
Rho(D) positive red cell membranes and Rho(D) positive En(a-) red cell membranes: (A) standard proteins, see legend to f&l; 
(B) pattern of periodate/NaBSH,-labeled red cell membranes; (C) pattern of 1z51-labeled Rho(D) positive red cell membranes; (D) 
pattern obtained with anti-Rho@) antiserum from Rho(D) positive red cell membranes; (E) pattern obtained with non-immune 
serum from an identical sample as in (D); (F) pattern obtained with antiserum from Rho(D) positive En(a-) red cell membranes; 
(G) pattern obtained with non-immune serum from an identical sample as in (F). Symbols as in legend to ilg.1. ( _ ) Rho(D) 
antigen. The weakly labeled band just above CPA-M in D and F is actin, which non-specifically may bind to immunoprecipitates. 
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>20 Rho(D) positive cell samples but has never been 
obtained from Rho(D) negative cells. Several poly- 
peptides were non-specifically adsorbed to the Staph- 
ylococci, among them glycophorin A and a protein 
migrating in the band 3 position. These are the most 
strongly labeled surface polypeptides of red cells and 
evidently represent ‘background’ radioactivity. 
The app. M, of the Rho(D) polypeptide was 
28 000 using an 8% acrylamide slab gel whereas the 
app. Mr was 33 000 using a 12% gel. The major red 
cell sialoglycoprotein, glycophorin A, which binds 
relatively low amounts of SDS [ 15,161 and is relatively 
hydrophilic due to its 60% content of carbohydrate 
gave a higher app. Mr on the 8% acrylamide gel than 
on the 12% gel (cf. fig.lD,2D). Thus the Rho(D) 
antigen migrated near the glycophorin A monomer on 
12% gels but much faster on 8% gels. This indicated 
that the Rho(D) antigen binds relatively more SDS 
and is more hydrophobic [ 171. 
The antigen is weakly labeled in the intact cell 
which indicates that it is a minor component. Previous 
quantitation has given values of 20 000-32 000 anti- 
genie sites/cell [ 181. In contrast some major compo- 
nents like glycophorin A and band 3 are found in lo6 
copies/cell [19,20]. But the Rho(D) antigen may well 
be deeply embedded in the membrane and thus rather 
inaccessible to external reagents. In fact, protease 
treatment does not destroy the antigen in intact cells 
[21,22], whereas the isolated polypeptide was readily 
degraded. 
We have performed immunoprecipitations with 
anti-Rho(D) antisera from solubilized red cell mem- 
branes labeled by the galactose oxidase/NaB3H4 or 
periodate/NaB3H4 surface-labeling techniques, but no 
labeled band was obtained. It may be that the protein, 
although surface-located, does not contain carbohy- 
drate. 
Previous work on the molecular characterization 
of the Rho(D) antigen has given variable results. Early 
work was hampered by the lack of suitable techniques 
for the characterization of integral membrane pro- 
teins. In [3] an antigenically active fraction was iso- 
lated by elution from anti-Rho(D) IgG-Sepharose 
columns. After staining with Coomassie brilliant blue 
they observed a diffuse band migrating near the buffer 
front on SDS gel electrophoresis. The est. Mr was 
7000. Unfortunately, the affinity chromatography was 
performed at room temperature, which could have 
resulted in proteolysis. Another possibility is that the 
eluate indeed contained the intact antigen, but it was 
96 
not stained due to its hydrophobic nature. 
In [4] it was claimed that the anion transport pro- 
tein band 3 carries the Rho(D) antigen activity. Their 
conclusion was based on the adsorption of band 3 
molecules to anti-Rho(D) IgG columns. The results 
are difficult to interpret because the band 3 poly- 
peptides were extensively fragmented. In addition it 
is known that band 3 is easily aggregated [23,24] and 
a diminution in the gel profile of the eluted controls 
is not conclusive. Furthermore, the number of band 3 
molecules found per cell does not agree with the 
estimation of the number of Rho(D) antigenic sites. 
This identification of the Rho(D) polypeptide 
should facilitate its large scale purification. Antiserum 
production by immunization with the purified antigen 
would be highly desirable and may then become pos- 
sible. 
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